Development and Assessment of Nomogram Based on AFP Response for Patients with Unresectable Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) have been increasingly used to treat hepatocellular carcinoma (HCC) but lack effective biomarkers. Our study aimed to investigate the related factors affecting the efficacy of ICIs treatment and develop a prognostic nomogram for patients with unres...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Shen, Hui, Zheng, Ruiying, Sun, Yueting, Xie, Xiaoyan, Lu, Ming-De, Liu, Baoxian, Huang, Guangliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647527/
https://www.ncbi.nlm.nih.gov/pubmed/37958306
http://dx.doi.org/10.3390/cancers15215131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647527/
https://www.ncbi.nlm.nih.gov/pubmed/37958306
http://dx.doi.org/10.3390/cancers15215131

Ejemplares similares